relatilimab

What’s next for Bristol Myers' relatlimab?
EP Vantage
Wed, 03/23/22 - 10:36 am
Bristol Myers Squibb
relatilimab
Opdivo
Opdualag
melanoma
Immuno-Oncology Treatments Finding Success with Combination Therapies
BioSpace
Thu, 03/25/21 - 11:44 am
immuno-oncology
Opdivo
Bristol-Myers Squibb
clinical trials
relatilimab
Ibrance